SightfileU.S. market data from official filings

Companies › HAE

HAEMONETICS CORP MASS (HAE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000313143 · EDGAR filings · Updated 2026-07-28

HAEMONETICS CORP MASS (HAE) has reported institutional ownership of 0.1%, with 323 institutional managers holding positions valued at $2.67B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
0.1%
Institutional managers
323
Reported 13F value
$2.67B
Insider activity
43 trans.
$98.8K net buying
Data flags
1 active
from SEC filings

Filings this week (6)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, HAEMONETICS CORP MASS has 323 institutional holders and institutional ownership of 0.1%.

Insider activity

Insiders reported 43 transactions (1 buys, 0 sells) across 15 reporting insiders, with a net reported value of $98.8K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2022-02-08 (recurring since 2020-02-04) — source filing. The authoritative details are those stated in the filing itself.

Related companies

CARIS LIFE SCIENCES INC (CAI) · IMMUNOVANT INC (IMVT) · DISC MEDICINE INC (IRON) · 10X GENOMICS INC (TXG) · CATALYST PHARMACEUTICALS INC (CPRX) · BEAM THERAPEUTICS INC (BEAM)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.